P17.53 THE COMBINATION OF CARMUSTINE WAFERS AND FOTEMUSTINE IN RECURRENT GLIOBLASTOMA PATIENTS: OUR EXPERIENCE

Por Lombardi, G., Puppa, A. Della, Zustovich, F., Pambuku, A., Farina, P., Zagonel, V.
Publicado em 2014

Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Por Pinto, A, Aldinucci, D, Gattei, V, Zagonel, V, Tortora, G, Budillon, A, Cho-Chung, Y S
Publicado em 1992

Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art

Por Bergo, E., Lombardi, G., Pambuku, A., Della Puppa, A., Bellu, L., D'Avella, D., Zagonel, V.
Publicado no Biomed Res Int (2016)

Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma

Por De Vita, S, Zagonel, V, Russo, A, Rupolo, M, Cannizzaro, R, Chiara, G, Boiocchi, M, Carbone, A, Franceschi, S
Publicado em 1998

P08.65 Evaluation of Clinical Benefit in patients treated with Bevacizumab

Por Villani, V., Fabi, A., Lombardi, G., Bellu, L., Zagonel, V., Carapella, C. M., Sperduti, I., Vidiri, A., Pace, A.
Publicado no Neuro Oncol (2016)

P09.29 Anaplastic Astrocytoma (AA) and Glioblastoma (GBM): a real-life experience in Padua Neuro-Oncology Center

Por Lombardi, G., Bellu, L., Pambuku, A., Fiduccia, P., Della Puppa, A., Gardiman, M., Berti, F., D’Avella, D., Zagonel, V.
Publicado no Neuro Oncol (2017)

P04.17 DIAGNOSTIC VALUE OF PLASMA AND URINARY 2-HYDROXYGLUTARATE TO IDENTIFY PATIENTS WITH IDH-MUTATED GLIOMA

Por Lombardi, G., Corona, G., Farina, P., Puppa, A. Della, Bertorelle, R., Gardiman, M., Toffoli, G., Denaro, L., D'Avella, D., Zagonel, V.
Publicado em 2014

P09.28 MGMT promoter methylation status in glioblastoma (GBM) patients: a quantitative pyrosequencing approach and its prognostic role

Por Lombardi, G., Bellu, L., Bertorelle, R., Pambuku, A., Gardiman, M., Fiduccia, P., Della Puppa, A., Berti, F., D’Avella, D., Zagonel, V.
Publicado no Neuro Oncol (2017)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer

Por Bertorelle, R, Briarava, M, Rampazzo, E, Biasini, L, Agostini, M, Maretto, I, Lonardi, S, Friso, M L, Mescoli, C, Zagonel, V, Nitti, D, De Rossi, A, Pucciarelli, S
Publicado em 2013

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1...

Por Pignata, S, Scambia, G, Pisano, C, Breda, E, Di Maio, M, Greggi, S, Ferrandina, G, Lorusso, D, Zagonel, V, Febbraro, A, Riva, N, De Rosa, V, Gallo, C, Perrone, F
Publicado em 2007

Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab

Por Zulato, E, Bergamo, F, De Paoli, A, Griguolo, G, Esposito, G, De Salvo, G L, Mescoli, C, Rugge, M, Nardin, M, Di Grazia, L, Lonardi, S, Indraccolo, S, Zagonel, V
Publicado em 2014

CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

Por Gruss, H. J., Pinto, A., Gloghini, A., Wehnes, E., Wright, B., Boiani, N., Aldinucci, D., Gattei, V., Zagonel, V., Smith, C. A., Kadin, M. E., von Schilling, C., Goodwin, R. G., Herrmann, F., Carbone, A.
Publicado em 1996

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection

Por Schirripa, M, Bergamo, F, Cremolini, C, Casagrande, M, Lonardi, S, Aprile, G, Yang, D, Marmorino, F, Pasquini, G, Sensi, E, Lupi, C, De Maglio, G, Borrelli, N, Pizzolitto, S, Fasola, G, Bertorelle, R, Rugge, M, Fontanini, G, Zagonel, V, Loupakis, F, Falcone, A
Publicado no Br J Cancer (2015)

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

Por Fornaro, L, Cereda, S, Aprile, G, Di Girolamo, S, Santini, D, Silvestris, N, Lonardi, S, Leone, F, Milella, M, Vivaldi, C, Belli, C, Bergamo, F, Lutrino, S E, Filippi, R, Russano, M, Vaccaro, V, Brunetti, A E, Rotella, V, Falcone, A, Barbera, M A, Corbelli, J, Fasola, G, Aglietta, M, Zagonel, V, Reni, M, Vasile, E, Brandi, G
Publicado em 2014

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patien...

Por Ruzzo, A, Graziano, F, Galli, Fabio, Galli, Francesca, Rulli, E, Lonardi, S, Ronzoni, M, Massidda, B, Zagonel, V, Pella, N, Mucciarini, C, Labianca, R, Ionta, M T, Bagaloni, I, Veltri, E, Sozzi, P, Barni, S, Ricci, V, Foltran, L, Nicolini, M, Biondi, E, Bramati, A, Turci, D, Lazzarelli, S, Verusio, C, Bergamo, F, Sobrero, A, Frontini, L, Menghi, M, Magnani, M
Publicado no Br J Cancer (2017)

A Nutritional Approach to the Prevention of Cancer: from Assessment to Personalized Intervention

Por Di Furia, L., Rusciano, M.R., Leonardini, L., Rossi, P., Giammarchi, C., Vittori, E., Tilocca, S., Russo, F.L., Montuori, P., Triassi, M., Nardone, A., Giaimo, M.D., Migazzi, M., Piffer, S., Iaria, A., Trapasso, A., Firenze, A., Cristaudo, R., Revello, M., Castiglion, A., Zagonel, V., Iaccarino, G., Addis, A., Natale, L., Di Somma, C., Colao, A., Perra, A., Giova, K., Montuori, N., Illario, M.
Publicado no Transl Med UniSa (2016)